Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO)

Peer Review reports

Original Submission
14 Sep 2013	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
Resubmission - Version 3
	Submitted	Manuscript version 3
3 Dec 2013	Reviewed	Reviewer Report - brian slomovitz
8 Dec 2013	Reviewed	Reviewer Report - Caroline Billingsley
15 Jan 2014	Author responded	Author comments - Kristina Lindemann
Resubmission - Version 4
15 Jan 2014	Submitted	Manuscript version 4
Publishing
30 Jan 2014	Editorially accepted
5 Feb 2014	Article published	10.1186/1471-2407-14-68

Back to article page